LIVE: Cabinet approves nutrient-based subsidy rates for P&K fertilisers
Live news updates: Prime Minister Modi will attend a G20 meeting on Afghanistan; unions will honour the farmers who died in Lakhimpur Kheri.
Govt making efforts to meet gencos' coal demand, trying to raise supply to 2 MT per day: Joshi
Union Coal Minister Pralhad Joshi on Tuesday said the government is making full efforts to meet the coal demand of power producers and stressed that steps are being taken to soon ramp up the dry-fuel supply to two million tonnes per day, from the current overall dispatch of 1.95 MT per day.
"We at the ministry and Coal India Ltd (CIL) are making full efforts to meet the coal demand... Yesterday (Monday), we supplied around 1.95 million tonnes (MT) of coal. Around 1.6 million tonnes from CIL and the remaining from Singareni Collieries Company Ltd. All put together, 1.95 MT we have supplied," the minister said.
The statement comes at a time when the country's power plants are grappling with fuel shortages.
Ministry of Coal launches the next tranche of auction of mines for sale of coal
Over 1,200 protestors booked over protest in UP's Noida
An FIR was lodged on Tuesday against 1,200 to 1,500 protestors, including women, who have been charged with murder attempt, rioting, wrongful confinement, destruction of public property, among others, during an ongoing protest outside Noida Authority office here, officials said.
Around 1,200 to 1,500 accused people have been booked in the case and the FIR names 31 individuals that includes Bhartiya Kisan Parishad leader Sukhvir Khaleefa alias Sukhvir Pahalwan.
Biological E seeks DCGI's nod for phase-3 trial of Corbevax as booster dose
Hyderabad-based pharmaceutical company Biological E has sought permission from India's drug regulator to conduct the phase-3 clinical trial for its COVID-19 vaccine Corbevax as a single booster dose for those who have been fully vaccinated with Covishield or Covaxin.
Currently, phase 2/3 clinical trials of the second indigenously developed Corbevax, an RBD protein sub-unit vaccine to be administered in adults aged 18 years to 80 years, is underway and the results are likely to be declared this month.
The company, meanwhile, has put in an application seeking the nod of the Drugs Controller General of India (DCGI) to conduct the phase-3 clinical study of Corbevax as a single booster dose in those fully inoculated with either Covishield or Covaxin.
MS Dhoni not charging honorarium for services as the mentor of Indian team for the T20 World Cup: BCCI Secy
Retail inflation eases to 4.35% in Sept; IIP grows 11.9% in August
Consumer price inflation fell sharply to 4.35% in September from 5.3% in August. This marks the third consecutive month within the Reserve Bank of India's (RBI) tolerance band of 2%-6%.
Awaiting regulatory nod to launch Covaxin for children: Bharat Biotech
We want to build a new Kerala, aiming 2 mn jobs: Kerala CM Vijayan
Despite the coal crisis, we've tried to supply electricity to our citizens: Maharashtra Energy Minister
Vegetable prices increase in Delhi due to heavy rains in Maharashtra, Karnataka
Govt asks CIL to raise coal supply to power plants during Durga Puja
Govt to remove restrictions on domestic aviation capacity from Oct 18
DCGA hasn't approve Covaxin for 2-18 years yet: MoS Health
Bharat Biotech has submitted data from clinical trials in the 2-18 years age group for Covaxin to CDSCO
Approval to Covaxin is yet to be given by DCGI after the evaluation of Data for 2-18 years: Report
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Oct 12 2021 | 6:46 AM IST